You are here

  • Home
  • Archive
  • Volume 9, Issue 1
  • Medium-term impact of the SARS-CoV-2 mRNA vaccine against disease activity in patients with systemic lupus erythematosus

Article metrics

Article menu
Epidemiology and outcomes
Original research
Medium-term impact of the SARS-CoV-2 mRNA vaccine against disease activity in patients with systemic lupus erythematosus

 

Online download statistics by month:

Online download statistics by month: August 2022 to September 2024

AbstractFullPdf
Aug 2022856864146
Sep 202233533263
Oct 202216516756
Nov 202210110138
Dec 2022565625
Jan 2023787823
Feb 2023636322
Mar 2023424318
Apr 2023262814
May 2023262518
Jun 202337368
Jul 2023313111
Aug 2023404018
Sep 2023242511
Oct 202318183
Nov 202332317
Dec 2023393923
Jan 2024303013
Feb 202422229
Mar 2024232113
Apr 2024383813
May 2024333211
Jun 2024313014
Jul 2024372715
Aug 202411117
Sep 2024262613
Total22202214612